Arcellx Raises $115m To Advance Novel T-Cell Therapies

First CAR-T In Phase I, Second Construct Heading For Clinic

 
• By Mandy Jackson
Coins and seeds in jars
Arcellx's series C round will fund its T-cell therapy pipeline's growth • Source: Shutterstock

More from Financing

More from Business